Abstract
When visiting a patient for the first time, it is necessary to take enough time in order to include a comprehensive clinical evaluation; therefore, a checklist of assessment items is useful to get a comprehensive individual image of the patient and his/her disease. The VETF scoring system combines analysis of extent, stage of disease (staging), and disease progression (spreading), and Wood’s lamp is useful for a combined assessment of staging and spreading in the same selected area. Finally, subjective items impacting quality of life are also important to take into account for management purposes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The last version is also available online at http://content.nejm.org/cgi/content/full/360/2/160/DC1.
References
Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev. 2006;(1):CD003263.
Anonymous. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186:23–31.
Taïeb A, Picardo M, VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20:27–35.
Taieb A, Picardo M. Clinical practice. Vitiligo. N Engl J Med. 2008;360:160–9.
Gauthier Y. The importance of Koebner’s phenomenon in the induction of vitiligo vulgaris lesions. Eur J Dermatol. 1995;5:704–8.
Halder RM, Grimes PE, Cowan CA, et al. Childhood vitiligo. J Am Acad Dermatol. 1987;16:948–54.
Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16:208–14.
Liu JB, Li M, Yang S, et al. Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol. 2005;30:327–31.
Betterle C, Caretto A, De Zio A, et al. Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatologica. 1985;171:419–23.
Alimohammadi M, Björklund P, Hallgren A, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med. 2008;358:1018–28.
Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol. 1997;133:1525–8.
Hamzavi I, Jain H, McLean D, et al. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140:677–83.
Kunz B, Oranje AP, Labreze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195:10–9.
Porter JR, Beuf AH, Lerner A, Nordlund J. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1:73–7.
Kostopoulou P, Jouary T, Quintard B, et al. Objective vs subjective factors in the psychological impact of vitiligo: the experience from a French referral center. Br J Dermatol. 2009;161(1):128.
Sampogna F, Raskovic D, Guerra L, et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008;159:351–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Taïeb, A., Picardo, M. (2019). Evaluation, Assessment, and Scoring. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Cham. https://doi.org/10.1007/978-3-319-62960-5_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-62960-5_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62958-2
Online ISBN: 978-3-319-62960-5
eBook Packages: MedicineMedicine (R0)